Precision System Science, Co., Ltd (PSS) announced today that PSS and Nordiag ASA (Oslo, Norway) have entered into basic development agreement of reagents for next generation sequencer, development of such reagents protocols for SX-8G Compact and the distribution of the reagents by both companies. The genetic analysis market, using next generation sequencer, is currently $1 […]

SOUTH SAN FRANCISCO, Calif. – Fluidigm Corporation (NASDAQ:FLDM) today announced that the underwriters of its initial public offering have exercised in full their over-allotment option to purchase an additional 833,750 shares of Fluidigm common stock at $13.50 per share, less underwriting discounts and commissions. Together with the shares sold pursuant to the over-allotment option, Fluidigm […]

Genovis has acquired an exclusive license for a new technology that uses so-called upconverting nanoparticles as contrast agents in optical biomedical imaging. Genovis is acquiring the license from Lumito, a LUAB company, including an option to acquire the technology as a whole. The license grants exclusive rights to upconverting nanoparticles and to the technology required […]

ST. LOUIS – Sigma-Aldrich® Corporation (Nasdaq: SIAL) announces the following executive leadership appointments intended to more closely align its corporate structure with its strategic plan. Frank Wicks, President Research, will assume responsibility for the entire portfolio of Research products, including those in Research Essentials, Research Specialties and Research Biotech. This newly combined Research strategic business […]

SAN DIEGO, Calif. – ACEA Biosciences, Inc., a pioneer in the development of high-performance microelectronic systems for cell-based assays, diagnostics, and pharmaceutical research, is pleased to report the issuance of a new U. S. Patent for chemical compound screening, with important applications in the development of new pharmaceutical products. Testing and profiling of these candidate […]

IMGM Laboratories GMBH has purchased a Fluidigm Access Array™ System to use in its development and validation of targeted re-sequencing applications services. IMGM is the first Genomic Services Provider to offer the combination of the Fluidigm Access Array technology in conjunction with Roche’s 454 Next-Generation Sequencing Systems to its customers in Germany. The Fluidigm Access […]

Bridgewater, NJ. – LABVANTAGE Solutions, Inc., the leading provider of browser-based laboratory information management solutions (LIMS), today announced that a global medical technology company (the Company) has extended a three-year preferred vendor agreement with LABVANTAGE. CENTRALIZED, BEST PRACTICES BASED DEPLOYMENT In an effort to realize a significant cost reduction and minimize potential risk, the Company […]

FORT WORTH, Texas – The Center for Human Identification at the UNT Health Science Center recently received a three-year $3.5 million grant from Life Technologies Corporation (NASDAQ: LIFE), a leader in forensic DNA testing systems, to train researchers from around the world in forensic DNA analysis techniques. This first of its kind accelerated academic certification […]

SEATTLE – NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced it has rounded out its commercial management team with the hiring of Chris Grimley as Vice President of Marketing and Katherine Webster as Vice President of […]

Oxford, UK – Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, today announced that its Genefficiency™ and CytoSure™ array comparative genomic hybridization (aCGH) services have been accredited as meeting ISO/IEC 17025:2005 international standards by the United Kingdom Accreditation Service (UKAS). The award underlines the superior level of […]